Wells Fargo
EVH icon

Wells Fargo’s Evolent Health EVH Stock Holding History

Wells Fargo’s Portfolio EVH Stock Details EVH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$116K Sell
50,700
-85,824
-63% -$272K ﹤0.01% 5026
2025
Q4 		$546K Buy
136,524
+43,583
+47% +$242K ﹤0.01% 4425
2025
Q3 		$786K Sell
92,941
-306,453
-77% -$2.97M ﹤0.01% 3979
2025
Q2 		$4.5M Buy
399,394
+332,668
+499% +$3.06M ﹤0.01% 2564
2025
Q1 		$632K Sell
66,726
-2,724
-4% -$27.5K ﹤0.01% 3923
2024
Q4 		$781K Sell
69,450
-20,756
-23% -$365K ﹤0.01% 3884
2024
Q3 		$2.55M Sell
90,206
-835
-0.9% -$21.5K ﹤0.01% 2864
2024
Q2 		$1.74M Buy
91,041
+1,736
+2% +$44.3K ﹤0.01% 3091
2024
Q1 		$2.93M Buy
89,305
+5,592
+7% +$178K ﹤0.01% 2668
2023
Q4 		$2.77M Buy
83,713
+3,531
+4% +$99.9K ﹤0.01% 2646
2023
Q3 		$2.18M Sell
80,182
-45,240
-36% -$1.26M ﹤0.01% 2740
2023
Q2 		$3.8M Buy
125,422
+7,752
+7% +$251K ﹤0.01% 2368
2023
Q1 		$3.82M Buy
117,670
+34,878
+42% +$1.1M ﹤0.01% 2335
2022
Q4 		$2.32M Sell
82,792
-4,519
-5% -$130K ﹤0.01% 2671
2022
Q3 		$3.14M Sell
87,311
-4,518
-5% -$159K ﹤0.01% 2361
2022
Q2 		$2.82M Sell
91,829
-111,452
-55% -$3.25M ﹤0.01% 2527
2022
Q1 		$6.57M Sell
203,281
-60,091
-23% -$1.57M ﹤0.01% 2213
2021
Q4 		$7.29M Sell
263,372
-38,036
-13% -$1.09M ﹤0.01% 2167
2021
Q3 		$9.34M Buy
301,408
+21,557
+8% +$518K ﹤0.01% 2275
2021
Q2 		$5.91M Sell
279,851
-34,737
-11% -$696K ﹤0.01% 2715
2021
Q1 		$6.36M Sell
314,588
-75,582
-19% -$1.44M ﹤0.01% 2605
2020
Q4 		$6.25M Sell
390,170
-76,186
-16% -$1.01M ﹤0.01% 2523
2020
Q3 		$5.79M Buy
466,356
+35,066
+8% +$412K ﹤0.01% 2381
2020
Q2 		$3.07M Buy
431,290
+112,566
+35% +$754K ﹤0.01% 2915
2020
Q1 		$1.73M Sell
318,724
-42,979
-12% -$384K ﹤0.01% 3129
2019
Q4 		$3.27M Sell
361,703
-1,882
-0.5% -$15.3K ﹤0.01% 2932
2019
Q3 		$2.62M Buy
363,585
+91,518
+34% +$657K ﹤0.01% 3104
2019
Q2 		$2.16M Sell
272,067
-16,128
-6% -$191K ﹤0.01% 3280
2019
Q1 		$3.63M Sell
288,195
-113,720
-28% -$1.8M ﹤0.01% 2848
2018
Q4 		$8.02M Buy
401,915
+69,616
+21% +$1.61M ﹤0.01% 2027
2018
Q3 		$9.44M Sell
332,299
-11,472
-3% -$274K ﹤0.01% 2118
2018
Q2 		$7.24M Sell
343,771
-52,072
-13% -$986K ﹤0.01% 2353
2018
Q1 		$5.64M Buy
395,843
+37,657
+11% +$539K ﹤0.01% 2531
2017
Q4 		$4.41M Buy
358,186
+151,038
+73% +$2.13M ﹤0.01% 2687
2017
Q3 		$3.69M Sell
207,148
-552,576
-73% -$11.4M ﹤0.01% 2792
2017
Q2 		$19.3M Buy
759,724
+668,066
+729% +$16.1M 0.01% 1400
2017
Q1 		$2.04M Buy
91,658
+75,720
+475% +$1.45M ﹤0.01% 3184
2016
Q4 		$235K Buy
15,938
+6,708
+73% +$132K ﹤0.01% 4678
2016
Q3 		$227K Sell
9,230
-1,057,917
-99% -$24.7M ﹤0.01% 4406
2016
Q2 		$20.5M Buy
1,067,147
+180,809
+20% +$2.48M 0.01% 1289
2016
Q1 		$9.36M Buy
886,338
+77,429
+10% +$800K ﹤0.01% 1860
2015
Q4 		$9.8M Buy
808,909
+145,685
+22% +$2.15M ﹤0.01% 1852
2015
Q3 		$10.6M Buy
663,224
+94,034
+17% +$1.83M ﹤0.01% 1763
2015
Q2 		$11.1M Buy
+569,190
New +$10.6M ﹤0.01% 1828

Other funds holding EVH

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
CCM
Cadian Capital Management New York $821M AUM 14.36% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
RF
Rubicon Founders Nashville, Tennessee $138M AUM 61.96% 1-Year Est. Return
EC
Engaged Capital Newport Beach, California $303M AUM 2.09% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wells Fargo's EVH Position: Q1 2026 in Review

Wells Fargo reduced its Evolent Health (EVH) stake by 63% in Q1 2026, selling an estimated $272K and leaving 50,700 shares worth $116K. The position accounts for ﹤0.01% of the portfolio, ranked #5026.

Wells Fargo first reported a position in EVH in Q2 2015 and has held it in 44 quarters since. The position peaked at $20.5M in Q2 2016. 191 funds tracked by Wall St. Rank hold EVH as of Q1 2026.

  • Wells Fargo held 50,700 shares of Evolent Health worth $116K as of Q1 2026.
  • Wells Fargo sold 85,824 Evolent Health shares in Q1 2026, an estimated $272K.
  • Evolent Health made up ﹤0.01% of Wells Fargo's portfolio in Q1 2026, its #5026 holding.
  • Wells Fargo first reported a position in Evolent Health in Q2 2015 and has held it in 44 quarters since.
  • Wells Fargo's Evolent Health position peaked at $20.5M in Q2 2016.
  • 191 funds tracked by Wall St. Rank held Evolent Health as of Q1 2026.

Based on Wells Fargo's 13F filing for Q1 2026, filed 11 May 2026.